The 12 closest competitors and alternatives to Mangoceuticals, Inc. among pharmaceuticals companies — ranked by similarity to what Mangoceuticals, Inc. actually does, not by market-cap band.
Subscribe to see Mangoceuticals, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.
Mangoceuticals, Inc. is a pharmaceuticals company headquartered in Dallas, United States. It is publicly listed (MGRX) with a market capitalisation of $9.6M. Xcout tracks 8 named people at Mangoceuticals, Inc., including Eugene Johnston (Chief Financial Officer).
2 more named people on record for Mangoceuticals, Inc., with roles, board committees and tenure — see the full roster →
5 corporate events on record, with sources — see the full timeline →
Ranked by semantic similarity — how close each company is to Mangoceuticals, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar pharmaceuticals company
PharmaCielo Ltd., operating in conjunction with its subsidiary, is primarily engaged in the comprehensive cultivation, processing, and distribution of pharmaceutical-grade cannabis extracts, including tetrahydrocannabinol (THC), and associated medicinal products. Additionally, the company diversifies its offerings by providing telemedicine software. Its clientele spans a range of entities, such as health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies, across both Canada and Colombia. PharmaCielo also holds a strategic partnership with AssuredTrans Inc., and its corporate headquarters are situated in Toronto, Canada.
Biotech
Celia Group, Inc. operates a telehealth platform that provides personalized health optimization programs, prescription therapies, and science-backed peptide formulations. The company serves individuals seeking proactive care and customized treatments for longevity, weight management, immune support, and overall wellness.
Telehealth & Men's Health
Rugiet is a telehealth company that provides performance medicine and personalized health treatments for men, including medications for erectile dysfunction, testosterone support, and longevity.
Similar pharmaceuticals company
Petros Pharmaceuticals, Inc. is a pharmaceutical company dedicated to male health solutions. Their activities include both the commercialization and ongoing development of Stendra, a prescription PDE-5 inhibitor specifically designed for treating erectile dysfunction (ED). Furthermore, Petros is advancing H100, a proprietary topical formulation currently in development as a potential treatment for acute Peyronie's disease. The company's offerings also extend to a range of erectile dysfunction products, such as vacuum erection devices. Petros Pharmaceuticals, Inc. operates from its base in New York, New York.
Pharma
Dicot Pharma is a pharmaceutical company that develops new potency drugs targeting sexual dysfunctions in men. Its primary drug candidate, LIB-01, is designed to treat erectile dysfunction with a prolonged duration of action. The company serves patients and healthcare markets by focusing on next-generation treatments to improve quality of life.
Biotechnology & Pharmaceuticals
Vesalius Longevity Labs operates a B2Doctor platform that provides peptide therapeutics and related products exclusively to licensed healthcare providers and clinical networks. The company manufactures and distributes peptides across multiple delivery formats—including subcutaneous, transdermal, intranasal, oral, and topical—utilizing cGMP-aligned manufacturing and third-party verification.
Similar pharmaceuticals company
Clarus Therapeutics is a U.S. specialty pharmaceutical company focused on men’s health and testosterone replacement therapy. It developed JATENZO (testosterone undecanoate), an oral testosterone replacement treatment for adult men with hypogonadism associated with a medical condition.
Similar pharmaceuticals company
Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.
Similar pharmaceuticals company
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications.
Similar pharmaceuticals company
Cingulate Inc. is a biopharmaceutical enterprise currently in its clinical development phase, dedicated to devising therapeutic options for attention-deficit/hyperactivity disorder (ADHD). Leading its pipeline for ADHD are two drug candidates: CTx-1301 (dexmethylphenidate), which is currently progressing through Phase 3 clinical trials, and CTx-1302 (dextroamphetamine). The company is also engaged in the advancement of CTx-2103, a candidate intended for the management of anxiety disorders. Founded in 2012, Cingulate Inc. maintains its corporate headquarters in Kansas City, Kansas.
Similar pharmaceuticals company
Endo Medical provides pharmaceutical products and scientific medical information resources for healthcare professionals in the United States. The company distributes medications spanning various therapeutic areas, including endocrinology, urology, pain management, and specialized therapies, while offering tools to submit medical inquiries and report adverse events.
Similar pharmaceuticals company
GelStat Corporation operates as a consumer healthcare enterprise, specializing in the innovation, formulation, and commercialization of over-the-counter (OTC) and other non-prescription health solutions. Its diverse product portfolio addresses various common health concerns, featuring: GelStat Migraine, a patented remedy targeting migraine headache pain; Chews 2 Lose, an appetite-controlling gum designed to assist with weight management; All Natural Speed, formulated as an energy booster; and GelStat Sleep, intended to alleviate sleep disturbances and their related symptoms. GelStat distributes its solutions through a comprehensive network, reaching retailers, wholesalers, specialized distributors, and catalog merchandisers. This is achieved both through direct sales and via independent sales brokerage agreements. The corporation maintains its principal office in Palm City, Florida.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Mangoceuticals, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →